We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$92.6M
AUM Growth
+$5.75M
Cap. Flow
+$2.75M
Cap. Flow %
2.97%
Top 10 Hldgs %
32.24%
Holding
102
New
26
Increased
26
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.58M
2
VTRS icon
Viatris
VTRS
+$3.19M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.28M
4
ELV icon
Elevance Health
ELV
+$1.89M
5
MSFT icon
Microsoft
MSFT
+$1.76M

Top Sells

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$4.96M
2
NOW icon
ServiceNow
NOW
+$1.78M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.34M
4
CI icon
Cigna
CI
+$1.28M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 56.86%
2 Technology 15.15%
3 Communication Services 6.25%
4 Financials 3.98%
5 Consumer Discretionary 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
76
AnaptysBio
ANAB
$1.68B
$97K 0.1%
935
-4,693
-83% -$529K
RCUS icon
77
Arcus Biosciences
RCUS
$3.64B
$88K 0.1%
+5,698
New +$94.9K
GBT
78
DELISTED
Global Blood Therapeutics, Inc.
GBT
$46K 0.05%
+946
New +$52.8K
ZS icon
79
Zscaler
ZS
$27.3B
$36K 0.04%
+1,278
New +$37.4K
INGN icon
80
Inogen
INGN
$164M
$2K ﹤0.01%
20
-1,155
-98% -$141K
AMT icon
81
American Tower
AMT
$80.4B
– –
-3,233
Closed -$461K
CI icon
82
Cigna
CI
$74.6B
– –
-6,307
Closed -$1.28M
DXC icon
83
DXC Technology
DXC
$1.73B
– –
-14,199
Closed -$1.17M
HUM icon
84
CALL
Humana
HUM
$46.2B
– –
-1,800
Closed -$447K
NOW icon
85
ServiceNow
NOW
$129B
– –
-68,320
Closed -$1.78M
QQQ icon
86
PUT
Invesco QQQ Trust
QQQ
$484B
– –
-9,900
Closed -$1.54M
REGN icon
87
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-3,555
Closed -$1.34M
UHS icon
88
Universal Health Services
UHS
$10.5B
– –
-7,071
Closed -$801K
XBI icon
89
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-16,400
Closed -$1.39M
LCI
90
PUT
DELISTED
Lannett Company, Inc.
LCI
– –
-1,275
Closed -$118K
ZEN
91
DELISTED
ZENDESK INC
ZEN
– –
-35,126
Closed -$1.19M
HRC
92
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-7,086
Closed -$597K
MNK
93
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-24,500
Closed -$553K
ZAYO
94
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-34,190
Closed -$1.26M
JUNO
95
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-26,066
Closed -$1.19M
1 2 3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Partner Investment Management held 102 positions worth $92.6M, up 6.6% from $86.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management's Q1 2018 filing shows 26 new, 26 increased, 27 reduced and 15 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,719 shares worth $3.52M. The largest sale was Sienna Biopharmaceuticals, Inc., an estimated $4.96M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q1 2018 buy was Bristol-Myers Squibb: 55,719 shares worth $3.52M.
  • Partner Investment Management added most to Elevance Health in Q1 2018, an estimated $1.89M increase.
  • Partner Investment Management's biggest Q1 2018 reduction was Sienna Biopharmaceuticals, Inc., cutting an estimated $4.96M.
  • Partner Investment Management fully exited ServiceNow in Q1 2018, selling an estimated $1.78M.
  • Partner Investment Management's ten largest holdings make up 32% of its $92.6M portfolio in Q1 2018.
  • Partner Investment Management opened 26 new positions and closed 15 in Q1 2018.
  • Partner Investment Management's portfolio value rose 6.6% quarter-over-quarter to $92.6M.

Based on Partner Investment Management's 13F filing for Q1 2018, filed 15 May 2018.